510(k) K983697
K983697 is an FDA 510(k) premarket notification submitted by Roche Diagnostic Systems, Inc. for the device "MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITE". The FDA issued a decision of Substantially Equivalent on December 11, 1998. The device falls under product code DIO (Enzyme Immunoassay, Cocaine And Cocaine Metabolites), a Class II device regulated under 21 CFR 862.3250. Roche Diagnostic Systems, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 11, 1998
- Date Received
- October 21, 1998
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Cocaine And Cocaine Metabolites
- Device Class
- Class II
- Regulation Number
- 862.3250
- Review Panel
- TX
- Submission Type